Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- ChecktodayChange DetectedThe site revision identifier in the footer changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe clinical trial record for the completed eteplirsen study is displayed, with details on its design, participants, study locations, measured outcomes, and supporting documents.SummaryDifference51%

- Check21 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces an NIH terminology transition, saying that agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.